Valuation: PAVmed Inc.

Market Cap 38.37M 33.59M 31M 28.92M 54.49M 3.63B 55.47M 372M 144M 1.79B 144M 141M 6.24B P/E 2026 *
-1.71x
P/E 2027 * -4.19x
Enterprise Value 38.37M 33.59M 31M 28.92M 54.49M 3.63B 55.47M 372M 144M 1.79B 144M 141M 6.24B EV / Sales 2026 *
113x
EV / Sales 2027 * 58.8x
Free-Float
56.63%
Yield 2026 *
-
Yield 2027 * -
1 day-2.80%
1 week+11.32%
Current month-15.94%
1 month-15.28%
3 months-46.84%
6 months-26.41%
Current year-21.35%
1 week 4.31
Extreme 4.31
5.44
1 month 3.85
Extreme 3.85
6.5
Current year 3.85
Extreme 3.85
28.44
1 year 3.85
Extreme 3.85
28.44
3 years 3.85
Extreme 3.85
270
5 years 3.85
Extreme 3.85
4,365
10 years 3.85
Extreme 3.85
6,858
Manager TitleAgeSince
Compliance Officer 62 2023-03-31
Chief Executive Officer 60 2014-06-25
Director of Finance/CFO 69 2017-03-20
Director TitleAgeSince
Director/Board Member 60 2014-09-30
Chairman 60 2014-06-25
Director/Board Member 71 2014-12-31
Date Insider Type Main position Quantity % Market Cap.
04-01Free

Chief Operating Officer

110,000 1.7233%
04-01Free

Director

13,930 0.2182%
04-01Free

General Counsel

110,000 1.7233%
Change 5-day change 1-year change 3-year change Capi.($)
-1.12%+11.32%-71.07%-97.16% 38.37M
-0.86%+6.59%+23.39%-4.11% 188B
-1.18%-0.50%-26.17%+17.32% 144B
-0.85%+6.55%-3.46%-20.54% 136B
-2.40%-6.86%-60.46%-21.48% 64.63B
-0.64%+4.00%+15.62%-4.14% 52.5B
+0.41%-0.93%-27.33%-34.05% 43.4B
-0.34%+3.49%+11.09%+9.02% 37.52B
+1.09%+3.72%+6.14%+38.99% 36.22B
-2.20%-0.24%-14.18%-21.75% 29.59B
Average -1.06%+4.94%-14.64%-13.79% 73.23B
Weighted average by Cap. -0.94%+5.68%-5.31%-4.19%

Financials

2026 *2027 *
Net sales 340K 298K 275K 256K 483K 32.15M 491K 3.3M 1.28M 15.86M 1.28M 1.25M 55.27M 652K 571K 527K 492K 927K 61.69M 943K 6.32M 2.46M 30.44M 2.45M 2.4M 106M
Net income -20.96M -18.35M -16.94M -15.8M -29.76M -1.98B -30.3M -203M -78.86M -978M -78.74M -76.99M -3.41B -18.18M -15.91M -14.69M -13.7M -25.82M -1.72B -26.28M -176M -68.4M -848M -68.3M -66.77M -2.95B
Net Debt - -
Logo PAVmed Inc.
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates in the medical devices, diagnostics, and digital health sectors. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer to prevent esophageal cancer deaths. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells. EsoGuard is a bisulfite-converted next-generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. Its other subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices.
Employees
41
Date Price Change Volume
26-06-30 US$5.410 +0.93% 10,200
26-06-29 US$5.360 +6.14% 6,716
26-06-26 US$5.050 +16.09% 36,647
26-06-25 US$4.350 -6.85% 12,479
26-06-24 US$4.670 -0.22% 3,641
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
5.360USD
Average target price
36.00USD
Spread / Average Target
+571.64%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PAVM Stock